SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pierre S. who wrote (1814)5/11/1999 7:18:00 AM
From: Jeff Chan  Read Replies (1) of 14101
 
Hi Pierre...

I think Mark pretty well answered most of your questions. Here's some other points.

But will it pass FDA ?

One can never really know until one sees it in black and white.

I am trying to compare it to the only topical NSAID/analgesic I know the FDA has approved which is a Bayer product called Myoflex.I have used it on a few people and it appears to works as well as a placebo.

You'd be surprised...many of the especially the older products are only as good as or slightly better than placebo. Diclofenac which is the active non-steroidal anti-inflammatory in Pennsaid has been around for quite some time. The question is not whether diclofenac works but whether the vehicle that DMX has is able to allow transdermal delivery of the drug and whether this process works and is safe.

Where the same studies required, what was there sample size in phase3, will Pennsaid be judged the same way ?

The same type of studies are required by any company applying for a new drug submission. I can't speak for the FDA, but certainly at the Health Canada website, the Health Protection Branch actually provides a template for all manufacturers of data that is required and how it is to be presented.

Hope this helps.
Jeff C
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext